Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Depression as a predictor of occupational transition in a multiple sclerosis cohort.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Long-term benefits of induction therapy in NMO: a case report.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
MOG-IgG in neuromyelitis optica.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
Risk factors for idiopathic optic neuritis recurrence.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Immunotherapy of Neuromyelitis Optica.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Prediction of disability progression in fingolimod-treated patients.
CNS inflammation other than multiple sclerosis: How likely is diagnosis?
Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Pages